Aligos Therapeutics
ALGS
ALGS
41 hedge funds and large institutions have $25.5M invested in Aligos Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
62% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 13
Holders
41
Holding in Top 10
1
Calls
$5K
Puts
–
Top Buyers
| 1 | +$773K | |
| 2 | +$55.1K | |
| 3 | +$30.5K | |
| 4 |
CIA
Choate Investment Advisors
Boston,
Massachusetts
|
+$23.3K |
| 5 |
VF
Virtu Financial
New York
|
+$18K |
Top Sellers
| 1 | -$874K | |
| 2 | -$221K | |
| 3 | -$126K | |
| 4 |
NM
Newtyn Management
New York
|
-$118K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$94.5K |